The DOI matches its Crossref record, with a small difference in title or year; 71 of the 71 references it cites were found in a registry or an index; none of the 52 sources its claims cite is checked for support yet.
Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Open accessAbstract
IMPORTANCE: National epidemiologic information from recently collected data on the new DSM-5 classification of alcohol use disorder (AUD) using a reliable, valid, and uniform data source is needed. OBJECTIVE: To present nationally representative findings on the prevalence, correlates, psychiatric comorbidity, associated disability, and treatment of DSM-5 AUD diagnoses overall and according to severity level (mild, moderate, or severe). DESIGN, SETTING, AND PARTICIPANTS: We conducted face-to-face interviews with a representative US noninstitutionalized civilian adult (≥18 years) sample (N = 36 309) as the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III). Data were collected from April 2012 through June 2013 and analyzed in October 2014. MAIN OUTCOMES AND MEASURES: Twelve-month and lifetime prevalences of AUD. RESULTS: Twelve-month and lifetime prevalences of AUD were 13.9% and 29.1%, respectively. Prevalence was generally highest for men (17.6% and 36.0%, respectively), white (14.0% and 32.6%, respectively) and Native American (19.2% and 43.4%, respectively), respondents, and younger (26.7% and 37.0%, respectively) and previously married (11.4% and 27.1%, respectively) or never married (25.0% and 35.5%, respectively) adults. Prevalence of 12-month and lifetime severe AUD was greatest among respondents with the lowest income level (1.8% and 1.5%, respectively). Significant disability was associated with 12-month and lifetime AUD and increased with the severity of AUD. Only 19.8% of respondents with lifetime AUD were ever treated. Significant associations were found between 12-month and lifetime AUD and other substance use disorders, major depressive and bipolar I disorders, and antisocial and borderline personality disorders across all levels of AUD severity, with odds ratios ranging from 1.2 (95% CI, 1.08-1.36) to 6.4 (95% CI, 5.76-7.22). Associations between AUD and panic disorder, specific phobia, and generalized anxiety disorder were modest (odds ratios ranged from 1.2 (95% CI, 1.01-1.43) to 1.4 (95% CI, 1.13-1.67) across most levels of AUD severity. CONCLUSIONS AND RELEVANCE: Alcohol use disorder defined by DSM-5 criteria is a highly prevalent, highly comorbid, disabling disorder that often goes untreated in the United States. The NESARC-III data indicate an urgent need to educate the public and policy makers about AUD and its treatment alternatives, to destigmatize the disorder, and to encourage those who cannot reduce their alcohol consumption on their own, despite substantial harm to themselves and others, to seek treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 52 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lifetime AUD was associated with persistent depression (except moderate severity), panic disorder (except mild severity), specific phobia, and generalized anxiety disorder (except moderate severity).”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Comorbidity
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Odds of 12-month and lifetime AUD were greater among men and lower among black, Asian or Pacific Islander, and Hispanic than white respondents, regardless of severity.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Odds of 12-month and lifetime AUD were greater among respondents younger than 65 years, regardless of severity level.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lifetime AUD was associated with persistent depression (except moderate severity), panic disorder (except mild severity), specific phobia, and generalized anxiety disorder (except moderate severity).”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Comorbidity
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“prevalences of lifetime AUD, 8.6% (0.18%), 6.6% (0.18%), and 13.9% (0.31%), respectively.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Twelve-month prevalences of mild, moderate, and severe AUD were 7.3% (0.19%), 3.2% (0.13%), and 3.4% (0.12%), respectively”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“prevalences of lifetime AUD, 8.6% (0.18%), 6.6% (0.18%), and 13.9% (0.31%), respectively.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most groups of respondents in the lowest 3 income levels had greater rates of 12-month and lifetime severe AUD than those with the highest incomes.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which decreased with increasing severity to 30.1 years for mild AUD, 25.9 years for moderate AUD, and 23.9 years for severe AUD.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Rates of 12-month and lifetime DSM-IV AUDs in the NESARC-III were 12.7% and 43.6%, respectively”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes
- It may state two separate claims as one. 20
- Probably not a substantial claim. 9
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with respondents who attained postsecondary educational levels, respondents with educational levels less than high school had greater odds of severe and lower odds of mild 12-month AUD.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Prevalence, Onset, and Sociodemographic Correlates
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“AUD was associated with other substance use disorders, major depressive and bipolar I disorders, and antisocial and borderline PDs across time frames and severity levels”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Results > Comorbidity
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significant associations between persistent depressive disorder, post-traumatic stress disorder, panic disorder, and generalized anxiety disorder with lifetime AUD were also observed.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We generally found significant associations between 12-month and lifetime AUD and other substance use disorders, major depressive disorder, bipolar I disorder, specific phobia, and antisocial and borderline PDs when we controlled for sociodemographic characteristics and other disorders.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All measures of current disability were strongly related to 12-month AUD, increasing with AUD severity.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, these concerns are not relevant to 12-month comorbidity associations that demonstrated similar direction and magnitude as comorbid lifetime associations.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For more severe problems, effective medications include oral and extended-release naltrexone hydrochloride, acamprosate calcium, and disulfiram61-65”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
What the sources say
- Not checked yetcites [61] Lee JD Grossman E DiRocco D Extended-release naltrexone for treatment of alcohol dependence in primary care. J Subst Abuse Treat 2010 39 1 14 21 20363090
- Not checked yetcites [62] Maisel NC Blodgett JC Wilbourne PL Humphreys K Finney JW Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 2013 108 2 275 293 23075288 PMC3970823
- Not checked yetcites [63] Litten RZ Egli M Heilig M Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 2012 17 3 513 527 22458728 PMC3484365
- Not checked yetcites [64] Jørgensen CH Pedersen B Tønnesen H The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res 2011 35 10 1749 1758 21615426
- Not checked yetcites [65] Zindel LR Kranzler HR Pharmacotherapy of alcohol use disorders: seventy-five years of progress. J Stud Alcohol Drugs Suppl 2014 75 suppl 17 79 88 24565314 PMC4453501
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Comparisons between DSM-IV 12-month AUD diagnoses with and without the additional questions yielded virtually identical prevalences (12.7% and 12.2%, respectively), with near-perfect concordance (κ = 0.98)”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Alcohol Use Disorders
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Alcohol use disorder defined by DSM-5 criteria is a highly prevalent, highly comorbid, disabling disorder that often goes untreated in the United States.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Abstract > CONCLUSIONS AND RELEVANCE
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Test-retest reliability of AUDADIS-5 and DSM-5 AUD categorical diagnoses (κ = 0.60 and κ = 0.62, respectively) and dimensional criteria scales (intraclass correlation coefficient [ICC], 0.83 and 0.85, respectively) was substantial”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Alcohol Use Disorders
What the sources say
- Not checked yetcites [24] Grant BF Goldstein RB Smith SM The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend 2015 148 1 27 33 25595052 PMC5554948
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“showed fair to good concordance on AUDADIS-5 and PRISM-5 AUD diagnoses (κ = 0.49 and κ = 0.62, respectively) and excellent concordance (ICC, 0.81 and 0.85, respectively)”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Alcohol Use Disorders
What the sources say
- Not checked yetcites [25] Hasin DS Aivadyan C Greenstein E Grant BF Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders 2011 Columbia University, Department of Psychiatry New York, NY Fifth Edition (PRISM-5) Version
- Not checked yetcites [26] Hasin DS Greenstein E Aivadyan C The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample. Drug Alcohol Depend 2015 148 1 40 46 25604321 PMC4330104
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Prior NESARC findings55 show that participation in 12-step groups increases the likelihood of recovery, consistent with randomized clinical trials testing the efficacy of 12-step facilitation administered by health care practitioners.56”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
What the sources say
- Not checked yetcites [55] Dawson DA Goldstein RB Ruan WJ Grant BF Correlates of recovery from alcohol dependence: a prospective study over a 3-year follow-up interval. Alcohol Clin Exp Res 2012 36 7 1268 1277 22309217 PMC3349820
- Not checked yetcites [56] Kaskutas LA Subbaraman MS Witbrodt J Zemore SE Effectiveness of making Alcoholics Anonymous easier: a group format 12-step facilitation approach. J Subst Abuse Treat 2009 37 3 228 239 19339148 PMC2746399
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Rather than lack of insurance, fears of stigmatization and beliefs that treatment is ineffective explain the lack of AUD treatment in the United States.50-54”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
What the sources say
- Not checked yetcites [50] Cohen E Feinn R Arias A Kranzler HR Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2007 86 2-3 214 221 16919401
- Not checked yetcites [51] Keyes KM Hatzenbuehler ML McLaughlin KA Stigma and treatment for alcohol disorders in the United States. Am J Epidemiol 2010 172 12 1364 1372 21044992 PMC2998202
- Not checked yetcites [52] Lawson KA Wilcox RE Littlefield JH Pituch KA Erickson CK Educating treatment professionals about addiction science research: demographics of knowledge and belief changes. Subst Use Misuse 2004 39 8 1235 1258 15461020
- Not checked yetcites [53] Yoast RA Wilford BB Hayashi SW Encouraging physicians to screen for and intervene in substance use disorders: obstacles and strategies for change. J Addict Dis 2008 27 3 77 97 18956531
- Not checked yetcites [54] Town M Naimi TS Mokdad AH Brewer RD Health care access among US adults who drink alcohol excessively: missed opportunities for prevention. Prev Chronic Dis 2006 3 2 A53 16539794 PMC1563973
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“When untreated, AUD-related functional impairment also has been associated with diminished life chances, increased stressful life conditions, and increased risk for and severity of other psychiatric disorders, even after AUD remission.73”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
What the sources say
- Not checked yetcites [73] Hasin DS Grant BF Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 2002 59 9 794 800 12215078
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“no significant differences were found in the percentages of Hispanic, black, or Asian respondents, population density, vacancy rate, proportion of the population in group quarters, or proportion of renters at the segment level.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Sample
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“The SF-12v2 is a reliable and valid measure of current impairment widely used in population surveys.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Disability
What the sources say
- Not checked yetcites [41] Gandek B Ware JE Jr Aaronson NK Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project International Quality of Life Assessment. J Clin Epidemiol 1998 51 11 1149 1158 9817132
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“evidence-based behavioral treatments include 12-step facilitation,56 motivational interviewing,66-68 and cognitive-behavioral therapy.68-70”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
What the sources say
- Not checked yetcites [56] Kaskutas LA Subbaraman MS Witbrodt J Zemore SE Effectiveness of making Alcoholics Anonymous easier: a group format 12-step facilitation approach. J Subst Abuse Treat 2009 37 3 228 239 19339148 PMC2746399
- Not checked yetcites [66] Apodaca TR Longabaugh R Mechanisms of change in motivational interviewing: a review and preliminary evaluation of the evidence. Addiction 2009 104 5 705 715 19413785 PMC2756738
- Not checked yetcites [67] Vasilaki EI Hosier SG Cox WM The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol 2006 41 3 328 335 16547122
- Not checked yetcites [68] Martin GW Rehm J The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry 2012 57 6 350 358 22682572
- Not checked yetcites [69] Irvin JE Bowers CA Dunn ME Wang MC Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol 1999 67 4 563 570 10450627
- Not checked yetcites [70] Magill M Ray LA Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 2009 70 4 516 527 19515291 PMC2696292
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Respondents included a slightly higher percentage of men (48.1% vs 46.2%), a greater percentage of those aged 60 to 69 years (13.7% vs 12.6%), and smaller percentages of those aged 40 to 49 (18.1% vs 18.3%) and 30 to 39 (16.7% vs 17.4%) years than in the eligible sample.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Methods > Sample
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Lifetime comorbid associations with AUD may be subject to recall bias and bias in variation of associations by ages at onset of comorbid disorders.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The NESARC-III is also unique in providing current, comprehensive information on DSM-5 AUD and its correlates and comorbidity in the United States.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly to other large US surveys, we did not assess all psychiatric disorders.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The DSM-5 diagnosis of AUD is a highly prevalent, highly comorbid, disabling disorder often untreated in the United States.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Potential study limitations include differences in some aspects of survey methods between the 2001-2002 NESARC and the 2012-2013 NESARC-III and less than ideal reliability for a few diagnoses other than AUD.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Strengths of the NESARC-III include its large sample size, reliable and valid measures of AUD and other psychopathology, and rigorous study methods.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The NESARC-III was also cross-sectional.”
§ Epidemiology of DSM-5 Alcohol Use Disorder > Discussion
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Population segments not covered by the survey (homeless individuals, prisoners, and most treated individuals) have a higher prevalence of AUD than the covered population.
“Because some population segments were not covered (ie, homeless individuals, prisoners, and most treated individuals), estimates presented herein may underestimate the true prevalence of AUD.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although SUDs are gen erally associated with more severe consequences than substance misuse, the latter is much more prevalent 148- 150 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [149]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A recent epidemiological study showed particularly high comorbidity between AUD and major depressive disorder and bipolar disorder and comorbidity with personality disorders and anxiety disorders (Grant et al., 2015).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Grant et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“Alcohol use disorder (AUD) among firefighters is estimated at approximately 50% [7], nearly twice that of the general population [8].”
From Mindful attention training workshop for firefighters: Design and methodology of a pilot randomized clinical trial (2022) · cites this paper as [8]
In the citing paper
“For instance, in many countries, the highest prevalence of substance use problems is found among young adults, aged 18-25 [36], and a majority of these 'age out' of excessive substance use [37].”
From Addiction as a brain disease revised: why it still matters, and the need for consilience (2021) · cites this paper as [36]
In the citing paper
“Lower socioeconomic status is correlated with both AD41 and age at first birth42 and the current study suggests that shared genetic liabilities may be one potential mechanism for their observed relationship.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Claimed highest severe-AUD rates fall below the overall rates
MajorThe abstract calls the lowest-income group's severe-AUD prevalences the greatest, yet gives 1.8% and 1.5%. The corresponding overall severe-AUD prevalences are higher, at 3.4% and 13.9%; an overall rate cannot exceed the highest income-group rate.
“Prevalence of 12-month and lifetime severe AUD was greatest among respondents with the lowest income level (1.8% and 1.5%, respectively).”
“Twelve-month prevalences of mild, moderate, and severe AUD were 7.3% (0.19%), 3.2% (0.13%), and 3.4% (0.12%), respectively; prevalences of lifetime AUD, 8.6% (0.18%), 6.6% (0.18%), and 13.9% (0.31%), respectively.”
Lifetime severe-AUD rate is below the past-year rate in the same group
MinorFor the lowest-income group, the stated lifetime severe-AUD prevalence is 1.5%, below its 12-month prevalence of 1.8%. The paper defines lifetime diagnoses to include diagnoses in the preceding 12 months, so the lifetime rate cannot be lower for that group.
“Prevalence of 12-month and lifetime severe AUD was greatest among respondents with the lowest income level (1.8% and 1.5%, respectively).”
“Lifetime DSM-5 AUD diagnoses required at least 2 of the 11 criteria in the 12 months preceding the interview or previously.”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Self-citationGrant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., Pickering, R. P., & Kaplan, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.8.807 · Cited by 2,889
Self-citationDiagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2024) · doi:10.4135/9781071886229.n145 · Cited by 2,806
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,011
Mannes, Z. L., Shmulewitz, D., Livne, O., Stohl, M., & Hasin, D. S. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14701 · Cited by 37
Self-citationBerre, A. L., & Sullivan, E. V. (2016) · Neuropsychology Review · doi:10.1007/s11065-016-9323-3 · Cited by 37
Gowin, J. L., Sloan, M. E., Swan, J. E., Momenan, R., & Ramchandani, V. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5113-3 · Cited by 37
Mehta, K., Hoadley, A., Ray, L. A., Kiluk, B. D., Carroll, K. M., & Magill, M. (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agab016 · Cited by 36
Johnson, J. C. S., Byrne, G. J., & Pelecanos, A. M. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03834-1 · Cited by 36
An orbitofrontal cortex–anterior insular cortex circuit gates compulsive cocaine use
Chen, Y., Wang, G., Zhang, W., Han, Y., Zhang, L., Xu, H., Meng, S., Lü, L., Xue, Y.-X., & Shi, J. (2022) · Science Advances · doi:10.1126/sciadv.abq5745 · Cited by 36
Brown, Q. L., Shmulewitz, D., Sarvet, A. L., Young‐Wolff, K. C., Howard, T., & Hasin, D. S. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109940 · Cited by 37
Self-citationNalmefene for the treatment of alcohol use disorders: recent data and clinical potential
Soyka, M. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1146689 · Cited by 37
Acupuncture for substance use disorders: A systematic review and meta-analysis
Grant, S., Kandrack, R., Motala, A., Shanman, R., Booth, M. S., Miles, J. N. V., Sorbero, M. E. S., & Hempel, S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.02.034 · Cited by 38
Treatment of alcohol use disorder and co-occurring PTSD
Taylor, M., Petrakis, I. L., & Ralevski, E. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1263641 · Cited by 39
Marceau, E. M., Kelly, P. J., & Solowij, N. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.008 · Cited by 43
Earnshaw, V. A., Bergman, B. G., & Kelly, J. F. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.03.005 · Cited by 36
Eddie, D., Greene, M. C., White, W. L., & Kelly, J. F. (2019) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000512 · Cited by 36
McCabe, S. E., Veliz, P. T., Dickinson, K., Schepis, T. S., & Schulenberg, J. E. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30299-8 · Cited by 36
Aiken, A., Clare, P. J., Boland, V. C., Degenhardt, L. J., Yuen, W. S., Hutchinson, D. M., Najman, J. M., McCambridge, J., Slade, T. N., MCBRIDE, N. T., et al. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108204 · Cited by 41
Palzes, V. A., Parthasarathy, S., Chi, F., Kline‐Simon, A. H., Lu, Y., Weisner, C. M., Ross, T. B., Elson, J., & Sterling, S. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14477 · Cited by 36
Necho, M., Tsehay, M., Seid, M., Zenebe, Y., Belete, A., Gelaye, H., & Muche, A. (2021) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-00335-w · Cited by 36
Alcohol use disorder causes global changes in splicing in the human brain
Booven, D. V., Li, M., Rao, J. S., Blokhin, I. O., Mayfield, R. D., Barbier, E., Heilig, M. A., & Wahlestedt, C. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01163-z · Cited by 36
Racial and ethnic disparities in psychosocial evaluation and liver transplant waitlisting
Deutsch‐Link, S., Bittermann, T., Nephew, L. D., Ross‐Driscoll, K., Weinberg, E. M., Weinrieb, R. M., Olthoff, K. M., Addis, S., & Serper, M. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.01.011 · Cited by 36
Janiri, D., Nicola, M. D., Martinotti, G., & Janiri, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160607101400 · Cited by 36
Joffe, M. E., Centanni, S. W., Jaramillo, A. A., Winder, D. G., & Conn, P. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00200 · Cited by 36
Levitt, E. E., Syan, S. K., Sousa, S., Costello, M. J., Rush, B., Samokhvalov, A. V., McCabe, R. E., Kelly, J., & MacKillop, J. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106649 · Cited by 35
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans
Vickers‐Smith, R., Justice, A. C., Becker, W. C., Rentsch, C. T., Curtis, B. L., Fernander, A., Hartwell, E. E., Ighodaro, E. T., Kember, R. L., Tate, J., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21111097 · Cited by 35
Elbogen, E. B., Dennis, P. A., & Johnson, S. C. (2016) · Clinical Psychological Science · doi:10.1177/2167702615619363 · Cited by 27
Walsh, K., Gilmore, A. K., Frazier, P. A., Ledray, L. E., Acierno, R. E., Ruggiero, K. J., Kilpatrick, D. G., & Resnick, H. S. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13505 · Cited by 35
The Neurobiology of Panic: A Chronic Stress Disorder
Goddard, A. W. (2017) · Chronic Stress · doi:10.1177/2470547017736038 · Cited by 39
Addressing Unhealthy Substance Use in Primary Care
Pace, C. A., & Uebelacker, L. A. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.02.004 · Cited by 35
Pharmacogenetics of alcohol use disorder treatments: an update
Hartwell, E. E., & Kranzler, H. R. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1628218 · Cited by 37
Williams, E. C., Frost, M. C., Rubinsky, A. D., Glass, J. E., Wheat, C. L., Edmonds, A. T., Chen, J. A., Matson, T. E., Fletcher, O. V., Lehavot, K., et al. (2021) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2021.82.132 · Cited by 35
Walther, A., Grub, J., Ehlert, U., Wehrli, S., Rice, S., Seidler, Z. E., & Debelak, R. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100107 · Cited by 35
Salemink, E., Rinck, M., Becker, E. S., Wiers, R. W. H. J., & Lindenmeyer, J. (2021) · Psychology of Addictive Behaviors · doi:10.1037/adb0000642 · Cited by 37
Browne, K. C., Stohl, M., Bohnert, K. M., Saxon, A. J., Fink, D. S., Olfson, M., Cerdá, M., Sherman, S. E., Gradus, J. L., Martins, S. S., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.20081202 · Cited by 37
Self-citationMeasurement invariance of the Yale Food Addiction Scale 2.0 across gender and racial groups.
Carr, M. M., Catak, P. D., Pejsa-Reitz, M. C., Saules, K. K., & Gearhardt, A. N. (2016) · Psychological Assessment · doi:10.1037/pas0000403 · Cited by 35
Metabolomics biomarkers to predict acamprosate treatment response in alcohol-dependent subjects
Hinton, D. J., Vázquez, M. S., Geske, J. R., Hitschfeld, M. J., Ho, A. M., Karpyak, V. M., Biernacka, J. M., & Choi, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-02442-4 · Cited by 35
Savage, J. E., Salvatore, J. E., Alıev, F., Edwards, A. C., Hickman, M., Kendler, K. S., Macleod, J., Latvala, A., Loukola, A., Kaprio, J. A., et al. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13589 · Cited by 37
Zhu, H., & Wu, L.-T. T. (2018) · BMC Public Health · doi:10.1186/s12889-018-5982-8 · Cited by 40
Fernandez, A. C., Waller, R. E., Walton, M. A., Bonar, E. E., Ignacio, R. V., Chermack, S. T., Cunningham, R. M., Booth, B. M., Ilgen, M. A., Barry, K. L., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.021 · Cited by 35
Weinland, C., Mühle, C., Kornhuber, J., & Lenz, B. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.019 · Cited by 35
Jegede, O., Rhee, T. G., Stefanovics, E. A., Zhou, B., & Rosenheck, R. A. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114720 · Cited by 34
Weber, R., Eggenberger, L., Stosch, C., & Walther, A. (2022) · Behavioral Sciences · doi:10.3390/bs12070204 · Cited by 34
Bourgault, Z., Rubin-Kahana, D. S., Hassan, A. N., Sanches, M., & Foll, B. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797578 · Cited by 34
Subtypes in addiction and their neurobehavioral profiles across three functional domains
Drossel, G., Brucar, L. R., Rawls, E., Hendrickson, T. J., & Zilverstand, A. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02426-1 · Cited by 35
The Locus Coeruleus: Anatomy, Physiology, and Stress‐Related Neuropsychiatric Disorders
Reyes, B. A. S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70111 · Cited by 39
High prevalence of alcohol use disorders in patients with inflammatory skin diseases
Aljefri, K., Newbury‐Birch, D., Muirhead, C. R., Gilvarry, E. A., Araújo‐Soares, V., Reynolds, N. J., Kaner, E., & Hampton, P. J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15497 · Cited by 34
PTSD symptoms and alcohol-related problems among veterans: Temporal associations and vulnerability.
Simons, J. S., Simons, R. M., Keith, J. A., Grimm, K. J., Stoltenberg, S. F., O’Brien, C., & Andal, K. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000376 · Cited by 34
Levine, A. R., Carrasquillo, L., Mueller, J., Nounou, M. I., Naut, E. R., & Ibrahim, D. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2309 · Cited by 34
Xu, H., Li, H., Liu, D., Wen, W., Xu, M., Frank, J. A., Chen, J., Zhu, H., Grahame, N. J., & Luo, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.614396 · Cited by 34
Wang, P., Guo, P., Wang, Y., Teng, X., Zhang, H., Sun, L., Xue, M., & Liang, H. (2022) · Nutrients · doi:10.3390/nu14061213 · Cited by 34
Self-citationMcTernan, P. M., Levitt, D. E., Welsh, D. A., Simon, L., Siggins, R. W., & Molina, P. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.839390 · Cited by 35
Creswell, K. G., Terry‐McElrath, Y. M., & Patrick, M. E. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109552 · Cited by 34
Studer, J., Baggio, S., Dupuis, M., Mohler-Kuo, M., Daeppen, J., & Gmel, G. (2016) · Frontiers in Psychology · doi:10.3389/fpsyg.2016.00718 · Cited by 34
Sleep Quality in an Adult American Indian Community Sample
Ehlers, C. L., Wills, D. N., Lau, P., & Gilder, D. A. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6486 · Cited by 35
Distress tolerance and physiological reactivity to stress predict women's problematic alcohol use
Holzhauer, C. G., Wemm, S., & Wulfert, E. (2017) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000116 · Cited by 33
Klingensmith, N. J., Yoseph, B. P., Liang, Z., Lyons, J. D., Burd, E. M., Margoles, L. M., Koval, M. H., Ford, M. L., & Coopersmith, C. M. (2016) · Shock · doi:10.1097/shk.0000000000000709 · Cited by 33
The Myriad Influences of Alcohol Advertising on Adolescent Drinking
Berey, B. L., LoParco, C. R., Leeman, R. F., & Grube, J. W. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0146-y · Cited by 33
Reus, V. I., Fochtmann, L. J., Bukstein, O., Eyler, A. E., Hilty, D. M., Horvitz-Lennon, M. V., Mahoney, J., Pasic, J., Weaver, M. F., Wills, C. D., et al. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17205 · Cited by 33
Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Lohoff, F. W. (2020) · Pharmacogenomics · doi:10.2217/pgs-2020-0079 · Cited by 37
Athamneh, L. N., Lemos, R. F., Basso, J. C., Tomlinson, D. C., Craft, W. H., Stein, M. D., & Bickel, W. K. (2020) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000389 · Cited by 33
Haun, H. L., Lebonville, C. L., Solomon, M. G., Griffin, W. C., Lopez, M. F., & Becker, H. C. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.01.002 · Cited by 34
Kirkland, A. E., Browning, B. D., Green, R., Leggio, L., Meyerhoff, D. J., & Squeglia, L. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01594-8 · Cited by 33
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Lohoff, F. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.767506 · Cited by 37
Ketamine Treatment for Alcohol Use Disorder: A Systematic Review
Kelson, M., Burnett, J. M., Matthews, A., & Juneja, T. (2023) · Cureus · doi:10.7759/cureus.38498 · Cited by 35
Luderer, M., Kaplan-Wickel, N., Richter, A., Reinhard, I., Kiefer, F., & Weber, T. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.11.020 · Cited by 33
Athamneh, L. N., DeHart, W. B., Pope, D. A., Mellis, A. M., Snider, S. E., Kaplan, B. A., & Bickel, W. K. (2019) · Psychology of Addictive Behaviors · doi:10.1037/adb0000460 · Cited by 33
Tindimwebwa, L. K., Ajayi, A. I., & Adeniyi, O. V. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105428 · Cited by 36
Frone, M. R., Chosewood, L. C., Osborne, J. C., & Howard, J. J. (2022) · Occupational Health Science · doi:10.1007/s41542-022-00123-x · Cited by 32
An Animal Model of Alcohol Dependence to Screen Medications for Treating Alcoholism
Becker, H. C., & Lopez, M. F. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.02.006 · Cited by 35
Psychiatric Disorders and Crime in the US Population
Moore, K. E., Oberleitner, L., Zonana, H. V., Buchanan, A. W., Pittman, B. P., Verplaetse, T. L., Angarita, G. A., Roberts, W., & McKee, S. A. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.18m12317 · Cited by 32
Gorka, S. M., Teppen, T. L., Radoman, M., Phan, K. L., & Pandey, S. C. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz057 · Cited by 34
Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease
Knox, J., Scodes, J. M., Witkiewitz, K. A., Kranzler, H. R., Mann, K. F., O’Malley, S. S., Wall, M. M., Anton, R. F., & Hasin, D. S. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14386 · Cited by 32
Self-citationCorrelates of alcohol use disorder pharmacotherapy receipt in medically insured patients
Rittenberg, A., Hines, A. L., Alvanzo, A. A. H., & Chander, G. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108174 · Cited by 32
Efficacité des psychédéliques en psychiatrie, une revue systématique
Berkovitch, L., Roméo, B., Karila, L., Gaillard, R., & Benyamina, A. (2021) · L Encéphale · doi:10.1016/j.encep.2020.12.002 · Cited by 35
Patrick, M. E., Evans‐Polce, R. J., Parks, M. J., & Terry‐McElrath, Y. M. (2021) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2021.82.362 · Cited by 32
Burnette, E. M., Ray, L. A., Irwin, M. R., & Grodin, E. N. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14696 · Cited by 32
Livne, O., Shmulewitz, D., Sarvet, A. L., Wall, M. M., & Hasin, D. S. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21010073 · Cited by 35
Self-citationGarel, N., McAnulty, C., Greenway, K. T., Lespérance, P., Miron, J., Rej, S., Richard‐Devantoy, S., & Jutras‐Aswad, D. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109606 · Cited by 34
Alvarado‐Tápias, E., Aguado, D. M., Kennedy, K. F., Fernández‐Carrillo, C., Cots, M. V., Morales-Arráez, D. E., Atkinson, S. R., Clemente, A. P. G., Argemí, J., & Bataller, R. A. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06490-w · Cited by 32
Bujarski, S., & Ray, L. A. (2016) · Behaviour Research and Therapy · doi:10.1016/j.brat.2016.05.008 · Cited by 37
Contributions of mobile technologies to addiction research
Swendsen, J. D. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.2/jswendsen · Cited by 32
Stevens, A. K., Littlefield, A. K., Talley, A. E., & Brown, J. L. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.10.026 · Cited by 32
Cross-Species Alterations in Synaptic Dopamine Regulation After Chronic Alcohol Exposure
Siciliano, C. A., Karkhanis, A. N., Holleran, K. M., Melchior, J. R., & Jones, S. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_106 · Cited by 32
McCabe, S. E., West, B. T., Strobbe, S., & Boyd, C. J. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.07.012 · Cited by 32
Hasin, D., Shmulewitz, D., Stohl, M., Greenstein, E., Roncone, S., Aharonovich, E., & Wall, M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108294 · Cited by 31
Self-citationRehm, J., & Room, R. (2017) · Nordic Studies on Alcohol and Drugs · doi:10.1177/1455072517704795 · Cited by 31
Grant, S., Azhar, G., Han, E., Booth, M., Motala, A., Larkin, J., & Hempel, S. (2021) · PLOS Medicine · doi:10.1371/journal.pmed.1003822 · Cited by 31
Kornfield, R., Toma, C. L., Shah, D. V., Moon, T. J., & Gustafson, D. H. (2017) · Health Communication · doi:10.1080/10410236.2017.1350906 · Cited by 33
Aberrations of anterior insular cortex functional connectivity in nontreatment-seeking alcoholics
Halcomb, M., Chumin, E. J., Goñi, J., Džemidžić, M., & Yoder, K. K. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.12.016 · Cited by 33
Knox, J., Wall, M. M., Witkiewitz, K. A., Kranzler, H. R., Falk, D. E., Litten, R. Z., Mann, K. F., O’Malley, S. S., Scodes, J. M., Anton, R. F., et al. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.020 · Cited by 31
Self-citationNoradrenergic tone mediates marble burying behavior after chronic stress and ethanol
den Hartog, C. R., Blandino, K. L., Nash, M. L., Sjogren, E. R., Grampetro, M. A., Moorman, D. E., & Vazey, E. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05589-7 · Cited by 31
Alcohol use disorder and non‐fatal suicide attempt: findings from a Swedish National Cohort Study
Edwards, A. C., Ohlsson, H., Mościcki, E. K., Crump, C., Sundquist, J., Kendler, K. S., & Sundquist, K. (2021) · Addiction · doi:10.1111/add.15621 · Cited by 34
Glass, J. E., Matson, T. E., Lim, C. Y., Hartzler, A. L., Kimbel, K. J., Lee, A. K., Beatty, T. C., Parrish, R. S., Caldeiro, R. M., McWethy, A. G., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/25866 · Cited by 31
Memory impairment in alcohol use disorder is associated with regional frontal brain volumes
Fama, R., Berre, A. L., Sassoon, S. A., Zahr, N. M., Pohl, K. M., Adolf Pfefferbaum, A., & Sullivan, E. V. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109058 · Cited by 33
Shmulewitz, D., Stohl, M., Greenstein, E., Roncone, S., Walsh, C. A., Aharonovich, E., Wall, M. M., & Hasin, D. S. (2021) · Psychological Medicine · doi:10.1017/s0033291721003652 · Cited by 31
Self-citationVederhus, J., Pripp, A. H., & Clausen, T. (2016) · Substance Abuse Research and Treatment · doi:10.4137/sart.s39192 · Cited by 31
Typologies of PTSD clusters and reckless/self-destructive behaviors: A latent profile analysis
Contractor, A. A., & Weiss, N. H. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.124 · Cited by 33
Shorey, R. C., Elmquist, J., Gawrysiak, M. J., Anderson, S., & Stuart, G. L. (2016) · Mindfulness · doi:10.1007/s12671-016-0525-9 · Cited by 30
Lebeaut, A., Zegel, M., Leonard, S. J., Bartlett, B. A., & Vujanovic, A. A. (2021) · Journal of Dual Diagnosis · doi:10.1080/15504263.2020.1854411 · Cited by 30
PTSD symptom severity and impulsivity among firefighters: Associations with alcohol use
Bartlett, B. A., Smith, L. J., Lebeaut, A., Tran, J. K., & Vujanovic, A. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.06.039 · Cited by 30
Shukla, S., & Hsu, C. L. (2025) · Microorganisms · doi:10.3390/microorganisms13010067 · Cited by 31
Weisner, C. M., Chi, F. W., Lu, Y., Ross, T. B., Wood, S. B., Hinman, A., Pating, D., Satre, D. D., & Sterling, S. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0970 · Cited by 30
Metadata
- Authors
- Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Hasin, D. S.
- Affiliations
- National Institutes of Health (US)
- New York State Psychiatric Institute (US)
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2015-08-01
- Volume
- 72
- Issue
- 8
- Pages
- 757
- ISSN
- 2168-622X (ISSN-L)
- PMC
- PMC5240584
- OpenAlex
- W1839921965
- Semantic Scholar
- 6ee46a927f990bdf26640152b3c8d783f8a1d8ad
- Cited by
- 2,556
- References
- 71
- Citations by year
- 2026: 141 · 2025: 179 · 2024: 215 · 2023: 218 · 2022: 274 · 2021: 322 · 2020: 311 · 2019: 267 · 2018: 254 · 2017: 194 · 2016: 151 · 2015: 28
- FWCI
- 163.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- National Institute on Alcohol Abuse and Alcoholism (K05AA014223)
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- alcoholism, DSM-5 diagnostic criteria, prevalence, psychiatric comorbidity, substance use disorders, disability, treatment utilization, severity, lifetime prevalence, gender differences, income, marital status, personality disorders, anxiety disorders, depression, NESARC-III, United States adults, Native Americans, alcohol screening and brief intervention
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Alcoholism, Mental Disorders, Female, Health Surveys, Humans, Male, Middle Aged, Sex Factors, Socioeconomic Factors, United States, Comorbidity, Prevalence, Diagnostic and Statistical Manual of Mental Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
